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CHAPTER I 
.·. INTRODUCTION 
A. Tryptophan Metabolism 
1. The Kynurenine-3-Hydroxyanthranilic Acid Pathway 
The metabolism of tryptophan has been intensively studied since 
the discovery of tryptophan by Hopkins and Cole (1) in 1902. At 
least four reactions of tryptophan are known to be involved in its 
metabolism: (a) oxidation to formylkynurenine; (b) hydroxylation to 
5-hydroxytryptophan; (c) conversion to indole-3-acetic acid; • (d) 
fission to indole, pyruvic acid, and annnonia, 
The first compound to be identified as a product of tryptophan 
metabolism was kynurenic acid. It had been isolated from.dog urine by 
·Liebig. (2) in 1853 and was shown to be formed from tryptophan in this 
species by, Ellinger (3) in 1904. Following the discovery, of kynurenic 
acid by Liebig, Kotake and Iwao (4) discovered kynurenine as a tryptophan 
metabolite in rabbit urine following tryptophan administration and 
Musajo (5) isolated xanthuranic acid from the urine of rats. In 1945, 
Elvehjem and coworkers (6) reported that niacin-deficient rats resumed 
growth if tryptophan was added to the diet. Their findings strongly 
.· suggested that tryptophan was being converted .to niacin. Rosen ~ al. 
(7) showed that the urinary excretion of nicotinic acid and its derivat·ives 
by rats was increased following.tryptophan administration. Similar findings 
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in man and other species were quickly recorded. In 1947 Beadle et al . 
. (8) reported that a mutant of :t{eurospora, requiring tryptophan or niacin 
for growth, could also utilize kynurenine and that it converted excess 
kynurenine to niacin in the medium. The conversion of L-tryptophan.to 
·kynurenine was first observed in vitro by Kotake and Masayama (9), who 
named the enzyme system responsible 11tryptophan pyrrolase." 
The details of the conversion of tryptophan to kynurenine were first 
elucidated by Knox and Mehler (lo, 11) using rat liver preparations. 
However, more detailed studies on tryptophan pyrrolase have been carried 
out recently. A 1000-fold purified apotryptophan pyrrolase was obtained 
from rat liver by Greengard and Feigelson (12). This apotryptophan 
pyrrolase has no catalytic activity unless supplemented with its cofactor, 
hematin. Protoporphyrin, mesoporphyrin., serotonin., epinephrine and some 
tryptophan analogs were reported to inhibit tryptophan pyrrolase activity 
(12, 13), L-Tryptophan, cortisol and chlorpromazine were found to 
increase tryptophan pyrrolase activity when administered to intact rats 
(14, 15; 16). However, adrenalectomized or hypophysectomized rats were 
reported to show a decrease in tryptophan pyrrolase activity (17, 18). 
Kynurenine can undergo at least three major reactions: (a) cleavage 
of the side chain to form anthranilic acid and alanine; (b) transamination 
to form o-aminobenzoylpyruvic acid which spontaneously cyclizes to form 
kynurenic acid;. (c) hydroxylation to form 3-hydroxykynurenine, The 
major pathway of kynurenine metabolism in mammals appears to be the con-
version to 3-hydroxykynurenine rather than formation of anthranilic acid 
or kynurenic acid. In yitro demonstration of the hydroxylation of 
kynurenic was accomplished by de Castro.? Price and Brown (19). They 
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demonstrated a NADPif dependent., oxygen•requiring enzyme in liver 
mitochondria which catalyzes the hydroxylation reaction. This system 
has also been described by Saito. et al. (20) and by:Kotake ~ al. (21). 
The enzyme has ·been partially pµrified (22) and thoroughly studied. (23, 24). 
Kynureninase, which was first observed by·Kotake (25)., in the presence 
of pyridoxal phosphate catalyzes the removal of the side chain frqm 
kynurenine and 3-hydroxykymirenine at about equal rates to . form alanine 
and anthranilic or 3-hydroxyanthranilic acids.,.respectively. The products 
formed by those reactions are two important intermediates·in the degrada-
tion of the indole nucleus. Anthranilic acid is involved in the aromatic 
pathway in Pseudomonas fluorescens and 3-hydroxyanthranilic acid is 
important in the oxidative pathway and in niacin synthesis in mammals and 
Neurospora. Kynureninases are formed in animal tissues (26., 27), bacteria 
(28) and Neurospora (29., 30). Pyridoxal phosphate is required for the 
enzymes from various sources. 
The existance of the kynurenine-3-hydroxyanthranilic acid pathway 
was also confirmed by the use of isotopes. Heidelberge,r et al. (31) 
found. that tryptophan-~-J.4c was converted to tirinary kynurenine-J.4c by 
dogs. Also, they found that tryptophan-~-J.4c did not give rise to 
* The following abbreviations aie used: NADPH, nicotinamide adenine 
trinucleotide (reduced form); NADP., nicotinamide adenine trinucleotide 
(oxidized form); NADH, nicotinamide adenine dinucleotide (reduced form); 
NAD, nicotinamide adenine dinucleotide (oxidized form);:3-0F{AA, 3-hydroxy-
anthranilic acid; Q.A., quinolinic acid;. P.A., picolinic aeid; N.A., 
nicotinic acid; Compound I, CX-amino-~-carboxylmuconic semiaidehyde;Compoµnd 
II, or a-HMS, a:-hydroxymuconic semialdehyde; NMN, nicotinamidemononucleo-
tide;·PRPP, 5-phosphoribosyl-l-pyrophosphate; p-CMB, p-chloromerc:uribenzQate; 
ex-AMA, CX"'.'aminomuconic acid; 0:-HMA., a:-hydroxymuconic acid; CoA,. Coenzyme A; 
Tris, Tris-(hydroxymethyl)aminomethane;·oEAE-cellulose, diethylamino-
ethylcellulose; a-KA, a:-ketoadipic acid;, DHKA, dehydro-a-ketqadipic acid; 
EDrA, ethylenediamine tetraacetic acid. 
labeled N1 -methylnicotinamide while tryptophan-3-14c did. (31, 32). The 
pathway for the conversion of tryptophan to niacin was thus confirmed. 
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Using tryptophan labeled with i 5 N in the indole ring Shayer · (33) further 
corroborated the kynurenine-3-hydroxyanthranilic acid pathway in mammals. 
Henderson and Hankes (34) found that DL-tryptophan-3a,7a,7- 1 4c was con-
verted to 14C-labeled quinolinic acid and N1 -methylnicotinamide in 
confirmation of the findings of Heidelberger !:..!:_ al. (31). The injection 
of 3-hydroxyanthranilic acid labeled with 14C in the carboxyl group also 
produced urinary N' -meth,ylnicotinamide containing-14C (35). The kyruurenine-
3-hydroxyanthranilic acid pathway of tryptophan metabolism as described 
above and related reactions are shown in Figure 1. 
2. Other Pathways 
As mentioned previously at least four reactions of tryptophan are 
involved in its metabolism and, among these reactions, the kynurertine-3-
hydroxyanthranilic acid pathway is most important in the degradation of 
tryptophan in mammals. Besides the conversion to a vitamin. (niacin) as 
mentioned above, tryptophan is also.the precursor of such diverse and 
biochemically important compounds as a neurohormone (serotonin), a phyto-
hormone (indoleacetic acid}; and an eye pigment in Drosophila (omrn.ochrome). 
5-Hydroxytryptamine or serotonin first observed by Erspamer as a 
physiologically active substance in 1954 (36),, was isolated and shortly 
afterward identified by Page, Rapport and their colleagues. (37). Thorson 
!:..!:_ &· (38) showed that human patients with carcinoid formed large amounts 
of 5-hydroxytryptamine (39). The findings of an enzyme in mammalian 
kidney (40) which decarboxylates 5-hydroxytryptophan but not tryptophan, 
7-hydroxytryptophan, or tyrosine and that the venom glands of the toad 
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Figure 1. Kynurenine·-3-hydroxyanthranilic acid pathway of tryptophan 
metabolism and related reactions 
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contain 5-hydroxytryptophan, 5-hydroxytryptamine, and N-methylated 
derivatives of 5-hydroxytryptamine, but no tryptophan indicate that 
6 
the conversion of tryptophan to 5-hydroxytryptamine may proceed by 
hydroxylation of tryptophan followed by decarboxylation of the hydroxylated 
derivative. The evidence for this pathway is very convincing. . It includes 
the results of both in vitro and in vivo.experiments employing isotopes 
and has been reviewed (41, 42). Serotonin is degraded by-liver and 
kidney homogenates to 5-hydroxyindoleacetic acid (43) and, 5-hydroxy-
indoleacetaldehyde was suggested as:an intermediate (4:,). 5.;.Hydroxy-
indoleacetic acid appears to be the.chief end-product of serotonin metabo-
lism in man.(43) atjd rat (44). 
The formation of indole-3-acetic acid from tryptophan in plants is 
of interest because 3-indole acetic acid (auxin) is a plant growth 
substance .. It was first isolated from human urine and identified by 
K8gl and coworkers in 1934 (45). In 1935,.Thimann (46) found that 
tryptophan was needed in the medium of Rhizopus for auxin production. 
The enzymes which catalyze the formation of indole acetate from tryp-
tophan in plants were reported in the following years (47, 48, 49). The 
view that tryptophan is the source of indoleacetic acid in plants (50, 
51), in animals (52), and in bacteria (52., 53) has been further confirmed 
by later experiments._ The synthesis of indoleacetic acid from tryptophan 
seems to be by two reaction sequences. One involves the transamination 
or oxidative deamination to indolepyruvic acid followed by decarboxyla-
tion. The other proceeds by decarboxylation to form tryptamine, then 
oxidative deamination with Il).onoamine oxidase to .give indoleacetaldehyde. 
Using 14C-labeled tryptopha~,Dannenburg and Liverman,(51) found that 
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watermelon slices convert tryptophan to a number of indole derivatives 
which were identified as indolepyruvic acid) indoleacetic acid) indole-
aldehyde) tryptamine and indole acetonitrile. The major route for 
auxin synthesis in this tissue appears to be through indolepyruvate) 
though other routes might be important as well (54). In animal tissues 
and bacteria, the pathway for indoleacetic acid formation also appears 
to proceed primarily via the transamination route (52). 
Onnnochromes, the eye pigments found in certain insects) were 
isolated (55) and tentatively identified as phenoxazine derivatives 
formed by condensation of two 3-hydroxykynurenine molecules (56). The 
conversion of tryptophan to the pigments of the eye of Callephora 
erythrocephala and the molting secretion of Vanessa were demonstrated 
with isotopes by Butenandt et al. (57) 56). 
B. Degradation of 3-Hydroxyanthranilic Acid 
1. 3-Hydroxyanthranilic Acid Oxidase 
It is known that 3-hydroxyanthranilic acid is a product of trypto-
phan degradation (59-62) and that it satisfies the nicotinic acid require-
ments of several organisms (63-66). The major pathway of oxidative 
degradation of tryptophan is via 3-hydroxyanthranilic acid in many 
organisms and mannnals (69). 3-Hydroxyanthranilic acid oxidase is known 
to catalyze the oxidation of 3-hydroxyanthranilic acid to a very unstable 
aliphatic compound) which may either bethespontaneously transformed into 
quinolinic acid or undergo enzymatic conversion to picolinic acid (70-72). 
In the early studies of this enzyme by Henderson (73), Schweigert (74) 
and their coworkers) rat liver slices and homogenates were used. In 
1959) a 4-fold purification of this enzyme was obtained by Stevens and 
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Henderson (75) from the acetone extract of ox liver. Two years later) a 
1600-fold purification of this enzyme was reported by_ Decker ~ al. (76). 
However) a few months after Decker's work) a 3000-fold purification of 
this enzyme was obtained by Iaccarino ~ ~- (77) 76). Recently) a 
further purification of this enzyme up to 3500-fold had been achieved by 
Vescia and Prisco (79), The properties of 3 -hydroxyanthranilic acid 
oxidase were thoroughly studied by these workers (75-60) using both 
partially and highly purified enzyme. 
3-Hydroxyanthranilic acid oxidase is a soluble enzyme found in the 
supernatant fraction of mammalian liver and kidney homogenates. It has 
been classified as a "phenolytic oxygenase" by Hayaishi et al. (61) 
since iso from molecular oxygen) rather than from water) is incorporated 
into quinolinic acid. Like other phenolytic oxygenases, this enzyme 
displays a specific requirement for ferrous iron (75) 76) 78) 82). 
Purified enzyme in the absence of FeS04 rapidly loses activity on aging. 
Addition of FeS04 at 1 mM reverses this effect and results in a slow 
activation. Reduc ed glutathione is less effective than FeS04 in main-
taining activity during storage at -20° C (80). Henderson I s group f ound 
that complete reactivation of the stored enzyme can be achieved after 
treatment with 0.1 mM ferrous sulfate at pH 3. 5 for 5 minutes (75) 60). 
In 1961, Iaccarino et~. (77 ) reported that the rate of enzymatic 
activity is dependent on the partial pressure of oxygen. They a lso 
concluded that excess of oxygen inhibited 3-hydroxyanthranilic acid 
oxidase. However, by using 1 mM Fe++ instead of the 0. 1 mM Fe++ used 
by Iaccarino ~ ~·) Vescia and Prisco (79) reported that a close 
proportionality was found between oxygen pressure and enzymatic activity. 
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No inhibition was observed at the highest partial pressures of oxygen. 
As is the case with many other enzymes, p-chloromercuribenzoate was 
reported to inhibit the activity of 3-hydroxyanthranilic acid oxidase at a 
low concentration (75). However , it was also observed that 3-hydroxyanthra-
nilic acid has a protective effect against p-chloromercuribenzoate (76). 
. +++ ++ ++ . . . Some cations such as Fe , Ca and Cd and anthranilic acid analogues 
were also reported to inhibit the enzymatic activity (79). With a 4-fold 
purified enzyme preparation, Stevens and Henderson (7 5) observed a sub-
strate inhibition phenomenon at a substrate concentration of 0 . 15 mM; on 
the other hand) Decker!:.!:_~. (76 ) _did not confirm this effect at a sub -
strate concentration a s high as 4 mM. However ) Vescia and Prisco (79) 
later showed that inhibition by excess substrate takes place both at pH 
6. 5 and 8 . The Km value of 3 -hydroxyanthranilic acid was found to be 2.1 
x 10-5 M. The optimal pH of 3-hydroxyanthranilic acid oxidase was found to 
be 7 . 5 (76 ). The highly purified enzyme preparation reveals a typical protein 
spectrum _with a single peak at 280 mµ and with a A2 eo to A260 ratio of J.:. 5 ,.(79), 
2 . The Products of 3-Hydroxyanthran i lic Acid Oxidation 
The reaction of 3 -hydroxyanthranilic acid oxidase with its substrat e > 
3-hydroxyanthrani lic acid , gives an unstable compound (Compound I; see Fig. 
2) which has an absorption max imum at 360 mµ (83 , 84). The formation of 
Compound I results from the oxidative fission of the benzene ring of 3-
hydroxyanthranilic acid in the 3- 4 position and one mole of oxygen per 
mole of substrate is required (83). The molar extinction coefficient of 
Compound I has been reported as 28 ) 300 (83 ) and 47 , 500 (85) 86 ) at 360 
mµ in different solvents . 
Compound I thus formed i s very unstable and is spontaneously con-
verted to quinolinic acid (87 ). Wiss!:.!:_~- (71) reported that under 
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Figure 2. Proposed Metabolic Pathway of 3-Hydroxyanthranilic Acid 
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acid conditions Compound I undergoes decarboxylation followed by con-
densation to form picolinic acid. However, Miyake ~ ~- (83) reported, 
independently, that mineral acids caused a shift in the absorption maximum 
from 360 mµ to 315 mµ; after neutralization the maximum was found at 375 
mµ instead of 360 mµ which suggested that a degradation had taken place 
to form a new compound. This degradation product, Compound II, was 
.found to react with carbonyl reagents, which indicated the new compound 
formed has carbonyl characteristics. 
The structure of Compound I has not been elucidated. The prepara-
tion of derivatives of Compound I by Wiss et aL (86) and the infrared 
spectra of these derivatives indicated that the structure of Compound I 
shown in Fig. 2 seems reasonable. 
As mentioned previously: Compound I is spontaneously degraded to 
quinolinic acid (87), Nearly quantitative yields of quinolinate were ob-
tained from rat liver preparations. However, the enzyme which catalyzes 
the formation of picolinic acid from Compound I was also found in the 
livers of bovine, guinea pig_, pig (79) and other species (89). This 
enzyme was also shown to be picolinic carboxylase by Mehler (88). The 
conversion of 3-hydroxyanthranilic acid to niacin has been clearly shown 
by nutritional (63) and isotopic (35) evidence. However, this conversion 
had not been demonstrated in vitro: until the recent work by Nishizuka 
et aL (81) and Gholson et !:!lo (91). 
HoweverJ the major portion of 3-hydroxyanthranilic acid is not 
metabolized via picolinic (89, 92), nicotinic (89) or quinolinic (86) 
acid, but via some other route. 
By using tryptophan·-3a,7a,7-l4c, Henderson and Hankes (34) found 
that 25 percent of the carbon-14 was expired as 14co2 12 hours after 
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injection into a rat. They.also showed (93) that 60 percent of the 
isotope from 3-hydroxyanthranilic acid-carboxyl-l.4 c was expired in 3 
hours. With tryptophan-7a-14c, Gholson~~- (94) found that 36.percent 
of the isotope was expired as 14co2 , and 40 to 50 percent was present· in 
the tissues 12 hours after injection. ·When3-hydroxyanthranilic acid-1-
14c was injected into rats tl).e isotope was found.in the methyl carbon 
of acetate (95), From all of these data, it can be concluded that the 
main route of tryptophan metabolism to CO2 is via 3-hydroxyanthranilic 
acid, and that 3-hydroxyanthranilic acid is.oxidized via Compound I to 
some aliphatic product .. In experiments designed to determine the possible 
metabolic steps between 3-hydroxyanthranilic. acid and CO2 , Gholson.·~ al. 
(96, 97) found that radioactivity from both tryptophan-7a- 1 4c and tritium 
. labeled 3'"hydroxyanthranilic acid was found in glutaric acid in the rat. 
The carbon-14 from tryptophan-7a-1 4c was found in the carboxyl carbon, 
again supporting the 3-hydroxyanthranilic acid - Compound I pathway for 
tryptophan metabolism. The proposed pathway. for the formation of glutaric 
acid from 3-hydroxyanthranilic acid is shown in Figure 2. 
Further evidence for the 3-hydroxyanthranilic acid- Compound I pathway 
was provided by the recent. in .vitro experiments of Hayaishi I s group (96) 
which provided evidence that Compound I is converted to glutaric acid 
in cat· liver homogenates via Compound II, a-hydroxymuconic acid~ a-keto-
adipic acid and glutaryl. CoA. M<:>re re~ent ly Hayaishi I s _group (90) has 
indicated th~.t 0:-aminomuconic semialdehyde and a.,-aminomuconic acid are the 
true intermediates rather.than the corresponding hydroxy compounds •. a-HMS 
dehydrogenase was found to·be present in the liver and kidney.·of rat, cat, 
beef and chicken. + + In the presence of NAD, but not NADP, this enzyme 
catalyzes the conversion of Compound II to a-hydroxymuconic acid. The 
reaction may be assayed by observing the decrease of the 375 mµ absorbtion 
peak of Compound II. a-HMS dehydrogenase is a very unstable enzyme. It 
loses activity rapidly during storage even at -15° C. p-CMB was found to 
. inhibit its activity. Because of its instability, this enzyme was only 
partially purified by Hayaishi's group (99) and in this laboratory. a-
Aminomuconic acid reductase from cat liver was only partially purified 
by Hayaishi's group (99) and a detailed study of this enzyme has not yet 
appeared, However, in order to further elucidate the 3-hydroxyanthranilic 
acid - Compound I pathway, higher purification and. detailed. studies of 
the enzymes mentioned above are necessary. 
C. Picolinic Carboxylase 
Tl).e existance of picolinic carboxylase in manunalian tissue was 
first reported by Mehler (88) in 1956. In this paper he stated that, 
n .. it has been found that in quinolinic acid production only the 
synthesis of the intermediate (Compound I) is enzyme-catalyzed; the sub-
sequent formation of quinolinic acid is spontaneous. An enzyme which' 
does attack the intermediate has been concentrated from extracts of 
liver .. This enzyme does not make or degrade quinolinic acid, but con-
verts the intermediate to picolinic acid." As mentioned previously, 
this enzyme was also found to occur in the livers of pigs, guinea pigs 
· (88) and other species (89). Because the activity of this enzyme is 
low in beef liver, Mehler (88) partially purified picolinic carboxylase 
from guinea pig liver by using acid treatment, gel absorption and ammonium 
sulfate fractionation. HCN and p-CMB were reported to inhibit picolinic 
carboxylase activity (88). The enzymewas reported to exhibit a broad optimum 
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from pH 6 to 9. 5. The product of this enzymatic catalyzed reaction was 
identified as picolinic acid both from its absorption spectrum and by 
paper chromatography, 
In studying the metabolism of 3··hydroxyanthranilic acid:. Decker (102.) 
stated that, "During the purification of the oxidase from beef liver it 
was.often observed that the 360 mµ maximum would decrease more rapidlythan 
that of a non-enzymatic control. This phenomenon was noted in all purifica-
tion steps but was particularly observed in the latter stages (Le. pH 
and gel treatment: 40-65 percent aunnonium sulfate precipitation)':. He 
also found that the enzyme activitywas inhib:itied by 2 x 10- 3 M cyanide 
or 0. 035 M ammonium sulfate. Using tritium·,labeled 3'"hydroxyanthranilic 
acid he identified the main product of this enzyme reaction to be pico-
linic acid, 
Recently the purification of picolinic acid carboxylase has been 
reported by Hayaishi I s group (99 ). A 50-fold purification of this enzyme 
from cat liver was obtained by the Japanese workers. * Mg was reported 
as a cofactor of this enzyme, 
Very little work has been done on the comparative study of the 
3-0HAA pathway of tryptophan oxidation. In 1957., Suhadolnik et~. (10'3) 
in a paper dealing with the metabolism of 3-hydroxyanthranilic acid in 
various mammalian species reported that) mouse, pig_, and rat liver ex-
tracts formed appreciable amounts of quinolinic acid but very little 
picolinic acido The picolinic carboxylase activity of mouse, pig and rat 
liver extract was less than extract from beef or cat liver. A comparative 
study of the metabolism of tryptophan via the 3-hydroxyanthran;i.lic acid 
pathway is a part of the present worlc The enzymatic activities of 3-
hydroxyanthranilic acid oxidaseJ picolinic carboxylase and a-hydroxymuconic 
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semialdehyde dehydrogenase in some species of mammals, insects, mollusks, 
annelids and fishes were assayed. Also, the amount of radioactivity in 
the CO2 expired by·the various species after injection withtryptophan-5-
14C or tryptophan-cx- 14c was measured. Picolinic carboxylase, an enzyme 
of the 3-hydroxyanthranilic acid pathway) was also partially purified from 
beef kidney and its properties were studied. 
The objectives of the present investigation were: 
. 1. To determine whether the oxidative metabolism of tryptophan 
proceeds by the same route in representative species of various. animal 
phyla as it does in mannnals. 
2. To purify picolinic carboxylase and study its properties in 
order0 to obtain more information about the physiological function of this 
enzyme in vivo. 
CHAPTER II 
EXPERIMENTAL PROCEDURE 
. A. Materials 
3-Hydroxyanthrani 1 ic. acid, p~chloromerct1ribenz oate sodium salt, . a,o:' -
dipyridyl. and Tris-(hydroxymethyl) aminomethane were obtained from California 
Corporation for Biochemical Research. 8-·Hydroxyquinoline and o-phenanthro-
line was obtained from the G. Frederick Smith Chemical Co., DEAE-Cellulose 
from Sigma Chemical Company, and Sephadex G..:.·25 .. from Pharm?,c°L9-j Upp~ala, 
Sweden. DL-Tryptophan-a-14C (100) and 3-hydroxyanthranilic acid-COOH-
14C (101) were synthesized in this laboratory. et-Hydroxymuconic semialdehyde 
was a gift from Dr. L. R. Morgan, Louisiana State University, School of 
Medicine. Chickens, earthworms, beef liver and kidney.w~re purchased from 
local sources. Cockroaches and snails were obtained from Dr. C. G. Beames 
· of the Department of Physiology, Oklahoma· State University. . Fish were 
.obtained from local ponds. 
B. Experimental Methods 
1. Comparative Study of Tryptophan Metabolism 
a. Purification of 3-Hydroxyanthranilic Acid Oxidase 
3-Hydroxyanthranilic acid oxidase was purified from beef liver accord-
. ing to the method of H. H. Kang (104) with the following modifications: 
+) the acid step was carried.out at pH 3.5 at 0° C and in the presence of 
1 x 10-3 M FeS04 , 2) calcium phosphate gel treatment was omitted and 3) 
the enzyme precipitated with ammonium sulfate was dissolved in cold de-
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ionized water which contained 1 x 10-3 M FeS04 • The purification was 
carried through to the second ammonium sulfate fractionation step (104) 
and the oxidase thus obtained was stored at -15° C until used.as described. 
b. PrepaJ"at ion of Compound I 
Compound I was alw~ys prepared 10 minutes before use by the follow-
ing method: one ml of 0.1 M, pH 7, Tris buffer was put into a test tube. 
0.5 ml of 3 x 10-3 M 3-hydroxyanthranilic acid solution and 0.5 ml of 
the second ammonium sulfate fraction of oxidase, containing 2.06 mg pro-
tein per ml with a specific activity 2470 units per mg protein were then 
added. The tube was shaken and then allowed to stand at room temperature. 
for about 5 minutes, at. which time the absorbency at 360 mµ had ceased 
to increase. Then the tube was placed in an ice-bath. The Compound I 
thus obtained was stable enough for assay of picolinic carboxylase for 
30 to 60 minutes stored at 0° C. 
c. Preparation of Compound II 
3-Hydroxyanthranilic acid (15.3 mg) was dissolved in a minimum 
amount of 2N HCl. Deionized water was then added to about 7 ml and 2N 
NaOH was added dropwise to neutralize the solution to pH 7 by using pH 
6 to 8 range pH paper, Deionized water was again added to make the final 
volume equal to 10 ml. The concentration of this solution was 1 x 10-2 
M. The·3-hydroxyanthranilic acid solution thus obtained was then put 
into a 50 ml beaker which was kept in an ice-bath. Ten ml of the second 
ammonium sulfate fraction.of 3-hydroxyanthranilic acid oxidase (contain-
ing 10. 3 mg protein per ml with a specific activity equal to 2,1no units 
.per mg protein) were then added to start the reaction. The reaction·was 
carried on with constant stirring by using a magnetic stirrer and O. lN 
NaOH was added occasionally to maintain the reaction mixtµre near pH .7. 
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The reaction was followed by removing aliquots (about 0.02 ml), diluting 
to about 10 ml with absolute ethanol and, measuring the fluoresence of 
3-hydroxyanthranilic acid with a electronic photofluorometer (Coleman 
Instruments Inc.). After the complete disappearence of fluoresence, the 
reaction mixture was adjusted to pH 1 by adding a few drops of 5N HCl and 
the solution was heated in a boiling water bath for 5 minutes. The solu-
tion was then cooled to room temperature under running _tap water and 5N 
NaOH solution was added dropwise to bring it back to neutral pH. Dena-
tured protein was centrifuged down with a clinical centrifuge and discarded. 
The brown colored solution thus obtained contained Compound II which has 
two absorption maximum in the ultraviolet at 375 and 265 mµ in O.lM, . pH 7, 
Tris buffer. The higher absorption peak at 375 mµ is due to the presence 
of Compound II and the smaller peak at 265 mµ may be due to the presence 
of quinolinic acid formed spontaneously from Compound I. The Compound II 
solution thus obtained was used for the assay of 0:-HMS dehydrogenase 
activity. Compound II is unstable during storage at -15° Candis con-
verted to an unknown compound having an absorption maximum at 380 mµ. 
This compound has no activity with 0:-HMS dehydrogenase. It, therefore , 
is then necessary to prepare fresh Compound II solution each time before 
use) er tD use a solution stored at -15° C not longer than 2 days in . order 
to assay for 0:-HMS dehydrogenase. 
d. Assays 
1) Method for the Assay of 3-Hydroxyanthranilic Acid 
Oxidase (104) 
a) Principle: The formation of Compound I results 
in an increase of absorbancy at 360 mµ. 
b) Procedure: Tris buffer , 2~8 ml 9f O.lM, pH 7 , 
and O. 1 ml of enzyme solution were added to a 3 ml volume cuvette with 
a light path of 1 cm. The reaction was• started by the addition of O. 1 
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ml 3 x 10-3 M 3-hydroxyanthranilic acid solution. The enzymatic activity 
was measured by following the increase of absorbancy at 360 mµ using the 
Cary Model 14 or Beckman DB recording spectrophotometer. 
c) Definition.of Unit and Specific Activity: the 
rate of the reaction was determined from the initial linear portion (10 
to· 20 seconds) of the absorbancy versus time curve. One unit of enzyme 
activity is defined as the amount of enzyme which converts 1 millimicro-
mole (mµMole) of substrate Jnto product per minute. Specific activity is 
defined as the number of units of enzyme per mg of protein. 
d) Determination of Protein: protein was determined 
both by the Folin-Ciocalteu (105) and 280 mµ/260 mµ method (104) for all 
the enzymatic assays. 
2) Method for the Assay of Picolinic · Carboxylase 
a) Principle: The decarboxylation of Compound I 
followed by spontaneous ring.closure to form picolinic acid results in a 
decrease of absorbancy at 360 mµ. 
b) Procedure: Potassium phosphate buffer, 2.7 ml 
of O. lM) pH 7.5, was put in a 3 ml cuvette and 0.2 ml of Compound I solu-
tion prepared as mentioned above was then added. This will usually give 
an absorbancy at 360 mµ around 1. 7 to 1. 9. The rate· of the spontaneous 
decrease at 360 mµ was followed until a constant rate was reached. The 
reaction was then started by the addition of 0.1 ml picolinic carboxylase 
enzyme solution. The rate of decrease of absorbancy at 360 mµ was followed 
by using the Beckman DB recording spectrophotometer. 
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c). Definition of Unit and Specific Activity: The 
enzyme activity was obtained by subtracting. the rate of spontaneous de-
crease of absorbancy at 360 mµ from the rate of decrease after addition 
of picolinic carboxylase. Qne unit of enzyme activity. is defined as 
the amount of enzyme which converts 1 millimicromole (mµMole) of substrate 
into product per minute. Specific activity is defined as the number of 
units of enzyme per mg of protein. 
3) Method for the Assay of.QHfMS.Dehydrogenase 
a) Principle: The oxidation of a:=hydroxymuconic 
semialdehyde (Compound II) to a:-hydroxymuconic acid results in a decrease 
of ab,sorbancy at 375 mµ. 
b) Procedure: Tris buffer, 2.75 ml of 0.1 M, pH 8, 
was put in a 3 ml volume cuvette. a:-HMS dehydrogenase enzyme solution, 
O. 1 ml, and O. 05 ml of Compound II solut.ion prepared as mentioned above 
were then added. This amount of Compound II will usually give an absorbancy 
of about 1.6 to l.9 at 375 mµ. However, the amount of Compound II and 
. buffer solution added can be varied in . order to, obtain. an approximately 
equal amount of substrate in the cuvette for each assay. The reaction 
was started by the addition of 0.1 ml 3 x.10"2 M.NADY The rate of decrease 
of absorbancy at 375 mµ was followed by using the Cary, Model .14 or Beckman 
DB recording spectrophotometer. 
c) Definition of Unit and Specific Activity: The 
rate of the reaction was determined from.the linear portion of the 
absorbancy, versus time curve. One unit of enzymatic activity is defined 
as the amount of enzyme which converts.I millimicromole (mµMole) of sub-
·strate into product per minute. Specific activity is defined as the 
number of urtitsof enzyme p<ermg of protein. 
e. Isotopic Measurements 
1) Collection of 1 4c02 
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Various amounts of 1 4C-labeled tryptophan as shown in Table :0: and 
mwere injected irttraperitoneally into the animals to be tested as 
shown in 'l'able JI a:nd m· separately. The animals were then put into a 
sealed metabolism chamber as shown in Figure 3. Tube-I contained about 
30 ml of 1 N of sodium hydroxide solution and tube II and III each con-
tained 5 rnl of 1 N sodium hydroxide solution .. The CO2 expired from the 
animal was trapped. in the sodium hydroxide solution in tubes II and III. 
After 8 hours -of collection, the radioactive CO2 trapped in the sodium 
hydroxide solution was measured as described below. 
2) Measurement of radioactivity 
Aliquots (2 ml) of the 1 N sodium hydroxide solution o-f tubes II 
and II were transferred separately into a combustion tube and a small 
amount of carrier sodium carbonate was added to aid the removal of 
carbon dioxide from the solution. The combustion tube was the connected 
to a wet combustion system ( 107) and 5 ml of 10 percent perchloric acid 
were then added. The CO2 evolved_ from the solution was collected into 
a vacuum ionization chamber and_, the radioactivity was measured by using 
the vibrating reed electrometer. (108). 
2. Picolinic Carboxylase 
a) Enzymatic Assay 
The method for assaying picolinic carboxylase was described above. 
b) Purification Procedure 
All of the following_ steps were carried out in the cold room at 3° 
· C unless• otherwise specified. 
Water 
Pump f 
Tube III 
Air 
Disperser 
Tube II 
Animals 
To Be Tested 
Figure 3, Metabolic chamber for the collection of respiratory CO2 
----~---Air 
. Tube. I 
[\) 
[\) 
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Step 1. Homogenization: 170 gm of beef kidney purchased 
from a local slaughter house and stored in a deep freeze (-15° c) were 
homogenized with four volumes.of deionized water (weight per volume) for 
one minute in a waring blendor at full speed. The homogenate was centri-
fuged for-· 1 hour at 12,800 x g. and 0° C. The precipitate was discarded 
and the supernatant solution retained. 
Step 2. Heat Treatment: the supernatant solution was heated 
in 20.0 ml portions. in a stainless steel beaker with stirring to 65° C in 
a 3 liter water bath at 85° C and kept at that temperature for· 1 minute. 
Then the solution was cooled down_rapid~y with stirring to below 10° C 
in an ice-bath. Denatured protein·was r~oved by centrifuging for 30 
minutes at 12,800 x g and 0° C, . 
Step 3. Acid Treatment: the resulting supernatant solution 
was adjusted to pH 5 with 2 N hydrochloric acid which was added dropwise 
with stirring in an ice-bath. After standing for 10 minutes, denatured 
protein was removed by centrifuging . for 30 minutes as before. 
Step 4. First Annnonium Sulfate Fractionation: a saturated 
solution of ammonium sulfate was prepared at 3° C, and concentrated 
ammonium hydroxide solution was added until the solution was pH 7 as 
determined by a Beckman pH meter. This saturated ammonium sulfate solution 
was added slowly with constant stirring to the supernatant obtained.from 
Step 3 until 50 percent saturation (v/v) was reached. The solution was 
allowed to stand with stirring for 20 minutes, then centrifuged at 12,800 
x g. for· 30 minutes, and the precipitate was discarded. More saturated 
ammonium sulfate solution was again added slowly with constant stirring 
until 75 percent saturation was.reached, the solution was.then allowed to 
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stand and centrifuged as before.. The precipitate was dissolved in 50 ml 
of cold deionized water. 
Step 5: Second Ammonium Sulfate Fractionation: this step was 
carried out in the same manner as the first ammonium sulfate fractionation, 
except that the fraction between 35 and 65 percent saturation in ammonium 
sulfate was collected and dissolved in 10 ml of cold deionized water. 
Step 6: Desalting: the second ammonium sulfate fraction was 
passed through a 2 x 20 cm Sephadex G-25 column, equilibrated in H2 0 and 
eluted with distilled water. The colored protein (red) was easily ob-
served as it passed through the column and the colored fractions were 
collected, 
Step 7: DEAE-Cellulose Chromatography: 
a. DEAE-Cellulose Column: About 20 gm of DEAE-cellulose 
(dry weight) were washed with 1 liter of lN NaOH solution, followed by 1 
liter of lN HCl solution, then with lN Na.OH solution again, and finally 
washed with distilled water until it was free from alkali. The acid and 
base washed DEAE··cellulose was then suspended in 400 ml of 0. 2 M, pH 7, 
potassium phosphate buffer. The pH was adjusted to 7 by the addition of 
0. 2M KH2 P04 solution on a Beckman pH meter with stirring. The neutralized 
DEAE-cellulose was then washed several times with distilled water. The 
DEAE-cellulose was then suspended in 100 ml of 0.01 MJ pH 7, potassium 
phosphate buffer, and packed into a 2 cm diameter column until it was 21 
cm in height. The column was a.gain washed with several hundred ml of 0.01 
M phosphate buffer,. pH 7. 
b, Elution: Ten ml of desalted enzyme solution from Step 
6 (containing 240 mg protein) was placed on the colunm, and eluted with 
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100 ml portions of 0.01, 0.05, 0.1 and 0.2 M, pH 7, potassium phosphate 
buffer. Seventy 5. 5-ml fr act ions were collected with a flow rate· of 
about 1 ml per minute. The absorbancy of each fraction at 280 and 260 
mµ was measured. Fractions containing ultraviolet-absorbing material 
were assayed for enzymatic activityo 
CHAPTER III 
RESULTS AND DISCUSSION 
A. Comparative Study of Tryptophan Metabolism 
1. Purification of 3-Hydroxyanthranilic Acid Oxidase 
The preparation of highly purified 3--hydroxyanthranilic acid oxidase 
is one of the most important steps in the study of the enzymatic degrada-
tion of 3-hydroxyanthranilic acid. In the present work .Compound I and II; 
which were used as substrates for the assay of picolinic carboxylase;.and 
ex-HMS dehydrogenase were prepared enzymatically by the action of 3-
hydroxyanthranilic acid oxidase on its substrate, 3-hydroxyanthranilic 
acid. Therefore, in order to obtain optimum results,. a highly purified 
oxidase was desired. The oxidase was purified as described by H. H. Kang 
(104) with only slight modifications. The second ammonium sulfate frac-
tion (4.5 to 65 percent saturation) was used in the present work. Although,:, 
.this enzyme preparation was usually a colorless protein solution, a very 
small amount of picolinic carboxylase activity was still present. This 
phenomena also had been noticed by Decker (102) who reported that it is 
somewhat difficult to separate these two enzymes. The presence of picolinic 
carboxylase activity can be detected by observing the increasing rate 
of 11spontaneous 11 decrease of absorbancy at 360 mµ in the presence of in-
creasing.amounts of oxidase. However, the presence of a small amount of 
picolinic carboxylase in the oxidase will not inter fer with the picolinic 
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carboxylase assay. Thus the second ammonium sulfate fraction·of 3-0HAA oxid-
ase was used for the following work. 
2, Enzymatic Assays 
a. 3-Hydroxyanthranilic Acid Oxidase 
The enzymatic oxidation of 3-hydroxyanthranilic acid between carbons 
3 and 4 of the benzene ring forms Compound I which has an absorption max-
imum at 360 mµ at neutral. Because of its high molecular extinction 
coefficient (e=28,300) at this wavelength, it provides a rapid and easy 
method for following the enzymatic reaction spectrophotometrically. 
Compound I is unstable at room temperature but was found to be 
stable when stored at 0° C .. The molecular extinction coefficient of 
Compound I at 360 mµ was determined as 28,300 at pH 7. 5 by Long ~ l!l· 
(83). In the present study it was found thee remained constant over a 
pH range of 7 to 9 but decreased to 20,000 at a pH of 5 or 6. 3-0HAA 
oxidase is assayed at pH 7 and therefore an e of 28,300 was used to cal-
culate the enzymatic activity. 
b. Picolinic Carboxylase 
The decarboxylation of Compound I by the action of pic.olinic car-
boxylase followed by non-enzymatic ring closure to form picolinic acid 
results in a decrease absorbanc.y at 360 mµ. Because Compound I is unstable 
at room temperature, the non-enzymatic spontaneous formation of quin.olinic 
acid will also cause a decrease of absorbancy at 360 mµ. The activity of 
picolinic carboxylase was therefore obtained by subtracting the rate of 
decrease of absorbancy at 360 mµ before the addition of picolinic carboxy-
lase from the rate of decrease after the addition of picolinic carboxylase. 
c. CX-Hydroxymuconic Semialdehyde Dehydrog,enase 
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a-Hydroxymuconic semialdehyde dehydrogenase, which catalyzes the 
oxidation of a-hydroxymuconic semialdehyde to the corresponding acid in 
the presence of NAD;° is a very unstable enzyme. Activity. was gradually 
+ . . 
.. lost during standing. both at 0° and -15° C. NADP could· not be sut>stituted" 
for NAD as a cofactor.for a-}IMS dehydrogenase, p-Chloromercuribenzoate 
was. found- fo•fitll{i.bit ttJi:ft"~ri:i'yme.···.,. 
a-Hydroxymuconic semialdehyde (Compound II or a-HMS),the substrate 
used for the assay of the dehydrogenase, was prepared by treating Compound 
I with acid and heat as described previously •. The Compound II solution 
thus obtained has two absorption maxima in the ultraviolet at pH 7, 375 
and 265 mµ, as . shown in Figure. 4. The higher peak at 375 mµ is due to 
the presence of Compound Ii, while the smaller peak around· 265 mµ is due 
to the presence of quinolinic acid formed by the non-enzymatic reaction 
from.· Compound I. Curve I of Figure 4 shows the absorption spectrum of 
chemically prepared .Compound II, a gift from .. Dr. L. R .. Morgan of Louisiana 
·State University. Both of these compounds·prepared by different methods 
are substrates. for a-HMS dehydrogenase. 
The molecular extinction coefficient of Compound II in alkaline solu·· 
· tion (pH 10. 5) at 375 mµ was reported to be 21,,000 by. Morgan (109). With 
. ·· chemically synthesized Compound II received from Dr. Morgan e was deter-
mined as 22,.200 in 0.1 M Tris buffer, pH 10. 5~ and as 19,600 in 0.1.M 
Tris buffer at pH 8. The molecular extinction coefficient of Compound II 
was. found to increase gradually when pH was increased, whereas in acidic 
solution, the 375 mµ peak shifted to 315 mµ. ?he activity of a-HMS de-
hydrogenase was calculated by using e=19,600 at pH 8, which was found to 
be the optimum pH for the dehydrogenase assay. 
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Figure 4: Absorption Spectrum of Chemically and Enzymatically 
. Synthesized a-HMS in O.lM) pH 7, Tris buffer. 
I. Chemically synthesized 
II. Enzymatically synthesized 
3. In vitro Study of Enzymatic Activities in Different Organisms 
Previous . in vivo and in vitro studies of tryptophan metabolism in 
mammals showed that·the kynurenine - 3-hydroxyanthranilic acid pathway is 
the major route for the degradation of tryptophan (69, 73, 74: 77, 79). 
The oxidation of the benzene ring of tryptophan via 3-hydroxyanthranilic 
.acid, a~hydroxymuconic semialdehyde and a-hydroxymuconic acid to glutaric 
acid was also suggested by results obtained in·Henderson's laboratory 
(96, 97) in whole animals and. in Hayaishi I s laboratory (89, 98) by in 
vitro studies. The comparative study described here was, undertaken.in 
order to determine if this pathway is also functioning in other groups 
of animals besides mannnals. 
The activities of 3-hydroxyanthranilic acid oxidase, picolinic 
carboxylase and a-hydroxymuconic semialdehyde dehydrogenase were assayed 
in ten different species as shown in Table I. All of the three enzymes 
were found in mannnals (rat and .cow). However, none of the three enzymat,ic 
activities could be found in earthworm, snail, cockroach, grasshopper or 
tetrahymena. In chicken liver, two of the three enzymes were detected 
but no picolinic carboxylase activity-was observed .. However, in fish 
(bass) liver, high activities of both oxidase and car boxy lase were 
detected, But, rather surprisingly no dehydrogenase was found. 
In the mannnals tested, all of the three enzyme specific activities 
were found to be higher in kidney than in liver. In fact in the case 
of picolinic ca:tboxylase, no .activity was detected in rat or beef liver 
under the assay conditions. The same result was also found in chicken 
liver. However, according to the reports of 0Mehler (72) and Decker (102) 
some picolinic carboxylase activity-was found both in rat and beef liver, 
TABLE.I 
ACTIVITIES OF 3-0HAA OXIDASE: PICOLINIC CARBOXYLASE AND Cl-HMS 
DEHYDROGENASE PREPARED FROM DIFFERENT ORGANISMS 
Enzyme 
Source 
Rat· Liver 
Rat Kidney 
Beef Liver 
Beef Kidney 
Protein-!~ 
Concentration 
(mg/ml) 
28.0 
.· 21. 7 
50.0 
28.6 
Fish Liver· (Bass) 28.6 
Chicken·Liver 
·Chicken Heart 
·Earthworm 
Snail 
Cockroach 
Grasshopper 
Tetrahymena 
Castor Cotyledon 
21. 7 
4.8 
16.0 
25.2 
12.9+ 
3,5 
+ 26.0 
Specific Activity ti: 
3-0HAA Picolinic a-HMS 
Oxidase Carboxylase Dehydrogenase 
127.5 
. 88. 7 
15.6 
45.5 
84.5 
21. 2 
0 
1.02 
0 
0 
0 
0 
0 
0 8.40 
3.91 
0 
2.27 0 
0 1. 95 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
* + Determined by method of Folin et a!.,. (105) except as noted which 
were determined by the 280 mµ/260" mµ ratio method ( 106). 
:I= mµmoles/mg Protein/min 
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although the amount was very small. Therefore, the probable explanation 
of the present results is that the amount of picolinic carboxylase present 
in rat -and beef liver is so. low that -it could not be detected under the 
assay conditions used. However, the present results evidently indicate 
that picolinic carboxylase in mammals is present mainly-in kidney-rather 
than in liver . 
. The failure to detect activity of any of the three enzymes in snail, 
cockroach, grasshopper;,_ earthworm and tetrahymena indicates that· trypto-
phan is probably not degradated via 3-hydroxyanthranilic acid to glutaric 
acid in these organisms. The observation of high activities of both 3-
hydroxyanthranilic acid oxidase and picolinic carboxylase but not of 
a-HMS.dehydrogenase in fish liver indicates that tryptophan may not be 
degraded via the pathway-of aliphatic colllPound formation to CO2 . It is 
possible that the true intermediate may be a~aminomuconicsemialdehyde 
rather than a-HMS (99) and that unlike the dehydrogenase from mammalian 
sources the fish liver dehydrogenase may be-specific for the 0:.,-amino 
compound .. An unknown special physiological function of picolinic acid 
and accumulation of picolinic acid in fishes may possibly provide an 
alternative explanation. However, no final conclusion can be given at 
present. 
4. In vivo· Studies of l.4c-Labeled Tryptophan Metabolism _in Different 
Species 
The results of the enzymatic assays presented in Table I show.that 
no .activities of oxidase, carboxylase or dehydrogenase were found in the 
tissue homogenates of snail, cockroach, earthworm and grasshopper. These 
findings suggest that the benzene ring of tryptophan is either not degraded 
in these organisms or is degraded by.a pathway_different from that found 
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in mannnals. In order to clarify this point tryptophan-5-14C was injected 
into thrse different·organism/:land the expired CO~ was collected for-about 
eight hours. The radioactivity-was counted by the use of a vibrating 
reed electrometer. The restJ.lts are shown in ·.Table II. 
Consistent with-the·restJ.lts.obtained from enzymatic.assays., tryptophan-
5-14c was not oxidized to 14C02 in-the grasshopper and cockroach. These 
restJ.lts indicate that the benzene ring_of tryptophan is not oxidative",1.y 
-degraded in these insects. On the other hand'the snail _and earthworm 
which also had no measurable activity-of any, of the three enzymes examined 
excreted from 3 to 6 percent of an injected dose of tryptophan-5-1 4c as 
14co2 • These results suggest that :j.n these two organisms •the··benzene 
ring of tryptophan is oxidized, but by.a different pathway than that 
found in mammals. As would be expected from the presence in chicken· .. liver 
of the enzymes of the 3-0HAA oxidase p~tl:iway., trypt9phan-5-l.4c was oxidized 
to 1 4co2 when injected intraperitoneally_ into. a l?aby chick. 
In order to see if the insect species were able to oxidize any portion 
of the tryptophan molecule as well as to compare the ·extent of oxidation 
:Of the side chain and bet).zene ring of tryptophan by the·other organism 
another ·series of experiments was carried out using tryptophan-o:- 1 4'c 
.(Table III). The percentage of the tryptophan.side chain oxidized to co2 · 
in the insects was low but measurable indicating that this portion of the 
molecule is degraded at·least to spme extent in these organisms. In the 
other species tested the larger percentage of l:-4 C02 was evolved from 
the side chain l,abeled tryptophan than from .the ring: labeled compound. 
This result is not surprising since in the known pathways of tryptophan 
\ 
nietabolism the side chain is removed before the ring_is attacked. It 
TABLE II 
EXCRETION OF 1 4c02 FROM DIFFERENT ORGANISMS AFTER 
INJECTION OF TRYPTOPHAN-5-14c 
Animals Time of· JAco2 Tryptophan i4c Recovered 
Organism Injected Wt/Animal Collection Injected in CO2 
gm hour mg mµc mµc % 
·. Grasshopper 2 2-3 4.5 0,2 122 0 0 
Snail 2 8 4.0 0,2 122 3.42 2.80 
2 8 8.o 0.2 122 4.22 3.46 
Earthworm .2 3-4 11.0 0.2 122 7,15 5.85 
2 3-4 8.o 0.2 122 4.79 3.93 
Cockroach 2 1~2 8,0 0,2 122 0 0 
2 1-2 8.o 0.28 267 0 0 
Chicken 1 106 8.o 15.0 1407 125.6 8.93 
TABLE III 
EXCRETION OF 14C02 FROM DIFFERENT ORGA..i.'HSMS AFTER 
INJECTION OF TRYPTOPHAN-a-1.4c 
Animals Tryptophan 1.4c Recovered 
Organisms Injected Wt/Animal 
. I Injected in CO2 
gm mg mµc mµc % 
Grasshopper 2 2-3 0.06 138.6 0 0 
2 2-3 0.06 138.6 1.23 0.89 
1 2-3 0.03 69.3 o.46 o.66 
Snail 2 8 0.06 138.6 2.01 1.45 
2. 8 0.20 119. 8 9.40 7.80 
Earthworm 2 3-4 0.06 138.6 4.36 3.14 
2 3-4 0.06 138.6 7.13 5.15 
Cockroach 2 1-2 0.06 138.6 0.91 o.66 
2 1-2 0.20 119. 8 1. 44 1. 20 
Chicken 1 63 0.15 347.0 22.43 6.50 
1 95 15.15 347.0 50.30 14.50 
14'C02 was collected for 8 hours in every case. 
35 
should be noted that·increasing the moles of tryptophan injected increased 
the percent of carbon-14 which wa.s excreted as lA,C0;:,:1 (grasshopper, snail) 
cockroach, chicken) (Table III) •. Extreme caution must therefore be 
observed in interpreting variations in amounts of 14C02 excreted from 
radioactive compounds unless the moles of compound injected and weight 
of the test organism are taken-into account. 
B. Purification and Properties of Picolinic Carboxylase 
1. Purification Steps 
The enzyme is water soluble and was readily extracted from kidney 
by homogenizing with four volumes of water. It is stable both to heat 
(65° c) and acid (pH 5). Heating to 65° C for 1 minut~ followed by rapid 
cooling to below. 10° C removed about 50 percent protein. A one-fold 
further purification was obtained by adjusting the prot.ein. solution to 
pH 5 after the heat treatment. Ammonium sulfate fractionation did not 
give a good purification and recovery. The only-purpose of this step 
was to concentrate the enzyme protein. Passing the ammonium sulfate 
fraction through a Sephadex G"'25 colurnnremoved the ammonium sulfate from 
the enzym.e protein and increased the apparent activity by about one fold . 
. DEAE-cellulose chromatography gave a 195-folds purification as compared 
with. the crude homogenate in the tube which had the highest specific 
activity. The most active four tubes gave an average of 83-fold purifi-
c_ation with a .spec.ific activity of 52. 8 and 20 percent recovery. A 
summary of the purification sequence and the DEAE-cellulose chromatography 
diagram is shown on Table IV and Fig. 5. 
2.. Properties of Picolini.c Carboxylase 
a. Reaction Catalyzed by Picolinic Carboxylase 
Fractions 
Homogenate 
Heat Treatment 
Acid Treatment 
First_Annnonium 
Sµlfate Fractionation 
(50 - 75%) 
Second hnmonium 
Sµlfat-e Fr-actl.l:lnat.i,on 
· (35 - 651%) 
Sephadex Column 
.- * 
, DEAE-Cellµlose 
Chron:iatography 
Volume 
(n1l) 
590 
545 
530 
55 
10 
.12. 5 
-22 
!ABLE IV 
PURIFICATION .. OF ··PICOLINIC CARBOXYLASE 
Activity 
(Units/ml) 
12.7 
12.7 
·12.7 
57.2-0 
164.0 
206.4 
68.3 
Total 
Units 
7500 
6920 
6730 
3140 
1640 
.2580 
1505 
Total 
·protein 
. (mg) 
11700 
4180 
2200 
780 
387 
300 
28.5 
· Specific 
Activity 
(Units/mg) 
o.64 
L 66 
3.06 
4.03 
4.25 
8.60 
52.80 
Recovery .Purification 
(%) 
100 
92.4 
90.0 
41. 9 
21. 9 
34.4 
20 
1 
2.6 
4.8 
6.3 
6.65 
13.4 
,83.0 
* The specific activity_ is t4e average of the four tubes which give the highest activities (tube No. 28-31). 
The highest activity-in tube 29 is 125 WQich gives a 195-fold purification. 
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Figure 5: DEAE-Column Chromatography of Picolinic Ca:tboxylase 
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Picolinic · car boxy lase catalyzes' the -'!3 .. deca:tpoxylation of Cm:p:pound I. 
The decathoxylated Compound I is presUI11edto·form picolinic acid almost 
. instantaneous.ly by a non-enzymatic reaction. The reactions are shown in 
the following: 
OOH · Picolin;i.c r· " 
· . . .·carhoxylase ~ 
OHC H-2 -----C-0~2--; : o:1d )l_. NH2 
COOR COOR 
Compound I Picolinic · Acid 
The removal of the 13-carboxyl group-of Compound I bythe action of 
p;icolinic carboxylase was detected by.-the use of Compound I - 13-COOR'.'"J.4c 
which was formed by the action of j-OHAA oxidase on· 3-0HAA-COOR-14c. The 
release of 1 4co2 from_ this substrate by the.action.of picolinic catboxylase 
as a function of time is shown inFig.-6. The disaµpearance,of the 360 
mµ.absorption maximum.of Compound I catalyzed by the enzyme, .followed by 
-the formation of an._absorption maximum_at 264 mµ. is shown in·Fig. 7. This 
result is the same as that reported by-Mehler (85) who identified the 264 
mµ absorbing_ compound which was identified as picolinic acid. 
The physiological role of picolinic carb.oxylase in vivo is not 
\ ' ' ---
entirely clear, It has been proposed (99) that picolinic carboxylase 
catalyzes the decarboxylation of the 13-carboxyl group of Compound I to 
form 0:-,,amminomuconic semialdehyde which.is then oxidized to.O:-aminomuconic 
acid by-a-HMS dehydro&enase. The dehydrogenase can apparently use either 
a-HMS or a-AMS as substrate. In the presence of NADPR a-,aminomuconic 
acid is reduced to 0:-ketoadipic acid which is then.further converted to 
glutaryl CoA. This proposed pathway is shown in Fig .. 5. Further work 
will probably be requi.red to ,evaluate the role of the a-amino ;compounds 
as opposed to the a-hydroxy compounds· in. this pathway. 
b, Effects of Buffer and Ammonium Sulfate 
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.Figure 6. Releasing of. 1 4co2 by the Reaction.of•Picolinic Carboxy-
iase from Compound I {Room Temperatur'e). . . 
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Figure 7. For~ation. of Picolinic.Acid 
by,-Picolinic Carboxylase at Room Temperatµre; 
pH 7. 
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~OOH 
HOOCI j(NH2 
.COOR 
Compound I P,A. 
Picolinic 1-co 
Carboxylase 2 
~ -~:-_:!~s--~ ~ 
HOJ . ~H2 · acid HOOCI ~OH 
.COOR COOR 
a~AMS a-HMS 
DeHase 1~AD + . DeHase ! NAD+ 
n ,__ -N~s -~~ ()1 
. acid 
HO NH2 · .HOOC OH 
COOR COOR 
I 
a-AMA 
Reductase 1.NADPH 
ijADH or r't NADPH 
HOJ O~COOHReductase 
a:-KA 
Glutaryl CoA 
Acetyl CoA 
a:-HMA l Isomerase 
~-
Hooc1 . A cooH 
. 0 
.DHKA 
Figure 8. The·Proposed Metabolic Pathway of 
Compound I to Glutaric Acid. 
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The type of buffer 4sed in the assay,-for picolinic carboxylase is 
very-important. At·the same concentration.and pH value, potassium phos-
phate buffer gives four-times more activity than the Tris buffer used 
previously. This is shown in Fig. 9 . 
. The inhibition· of enzymatic activity by_ the presence of aromoµium _s4lfate 
was observed during the purification-of this enzyme, Passage of ammonium 
sulfate fractionated enzyme through a Sephadex column resulted in a 
doubling of enzymatic activity which appears to be due to the removal of 
ammonium sµlfate. Table V shows the inhibition· of enzymatic activity with 
· increasing concentrations of ammonium sµlfate under the assay 0 cundition. 
Increasing the concentration up :to 0. 2 M re·sults: in 60 percent· loss-- of' 
activity. Further increase of ammonium sµlfate concentration gives no 
further increase ·of inhibition. 
c. Km and Optimum pH 
Picolinic carboxylase is a·rather stable enzyme; stored at -15° C 
without the presence of any-other protective reagents it lost no activity 
even. after months. This enzyme also shows a rather high affinity for its 
substrate. the ··Km value of this enzyme for Compound I was determit1.ed to 
be 4, 1 x 10- 5 M .. A curve which shows the relationship between inHial 
velocity and substrate concentration is presented in Fig. 10 and a Line-
weaver-Burk plot is shown in Fig. 11. 
Picolinic carboxylase has a rather broad pH optimum. Fig •. 12 shows 
that this enzyme has a maximum activity from pH 7. 5 to 8. 5. At pH 7 and 
9 only.a slight decrease in_activitywas found. However, in_acid pH the 
enzyme loses activity,-rapidly .and no reaction can ,be detected at pH :5, 
d. Effects of Metal Ions, Chelating Co:£1!pounds and Product on 
, Enzymatic Activity 
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Figure 9. Relationship Between the Enzyme Concentration and Activity. 
I. in 0. lM) pH 7) Tris Buffer 
II. in 0. lM) pH 7;, Potassium Phosphate Buffer 
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TABLE V 
, EFFECT ·0F AMMONIUM SUL.FATE ON PICf>LINIC -CARBOXYLASE ·ACTIVITY 
Concentration (mM) Activity (t:,,A/min.) <{o Activity 
0 0.160 100 
-LO 0.145 91 
5.0 0.120 75 
10.0 0.105 66 
50.0 0.080 50 
100.0 0.060 38 
-200.0 0.035 22 
300.0 0 .. 035 22 
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Figure 10 .. Effect of Increasing Substrate Concentration on 
the Velocity of Picolinic Carboxylase. 
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The ·effect. of. several metal. ions on tli.e activity of partially 
-pu:i;-·Hied .. p-icolinic · car boxy lase is shown in· Table VI, None of the metal 
.ions·tested·were found to.activate the·en.zyme. However.,.cu* ion at a 
concentration of 1 x -10- 4 M completely_ inhibited picolinic carboxylase 
activity. c~* inhibited about·30 percent at that concentration. Other 
ions·tested neither activated nor inhibited the enzyme. On.the other 
·# 
·hand.,. Hg was found to catalyze a rapid disappearance of Compound I to· 
: form. an unidentified compound.. This compound has an:. abso:rpt:ion maximum 
at 265 mµ. This compound has an Rf of 0,15, as detected by U.V. quenching, 
! ). . 
when.,chromatographed in butanol:acetic acid:water (.4:1:5). In this same 
solvent· system the Rf · values· for· QA_ and PA are 0. 40 and, 0. 30., respectively. 
The 13-carboxyl group of Compound I is not removed as was demonstrated by 
;+ . 
-the use of Compound I - -i=,-cocm-1 4c .. Mg·. was not found to be a cofactor 
for·this enzyme as had been-reported by-HayaiShi's g:roup,(99) .. Preincu-
bation with several chelating agents-(Table VII) for ·10 minutes before 
assay -only inhibited activity slightly or not at. all. Dialysis against 
5 x-10- 5 -M EDTA _at 0° C for 8 hours resµlted in only 27 percent·loss of 
total activity. These res4lts indicate that picolinic carboxylase is 
propably not a rne.tallo-enzyme. The ·product,. picolinic acid,. and its 
a~alogs:quinolinic and n.icotinic acids had little or no-inhibitory effect 
at a concentration of 1 x-10- 4 Molar. However, p-CMB at a concentration 
. of 1 x 10-4 .-.M completely inhibited the e11-zymatic activity,-indicat.ing 
that picolinic carboxylase is probably a sulfhydryl enzyme. 
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'J;ABLE VI 
EFFECT'OF'METAL IONS ON ENZYMATIC,ACTIVITY 
~eta ls , Concentration (mM) 'Activity (tA/min.) 
None 0 0. 15 
Fe-++ (FeS.04 ) 0.1 0.14 
++ Cti (CuS04) 0.1 0 
,++ ' 
Mg ,(MgCl2) 0.1 0.14 
-++ Mn (MnC12 ) 0.1 0.14 
-H-Co . (co(N03 ) 2 ) 0.1 0.13 
Ca ++ (ca (N03 ) 2 ) o. 1 0.10 
-H-Hg (RgCl2) 0.1 ? 
TABLE VII 
EFFECT OF CBE:t;,ATING AND-OTHER.COMPOUNDS ON:ENZYME ACTIVITY 
(Preincu9ated 10 Minutes-Before Assay) 
Compounds Concentration(m.M)_ Acti~ity(D.A/~in) 
None 0.16 
8-Hydroxyquin0line 0.1 0.12 
EDTA 0.033 o. 115 
a,a• -Dipyridyl o. 1 0.150 
o-Phenanthroline o. 1 0.150 
p-Chloromercuribenzoate 0. 1 0 
Picolinit Acid 0.1 0.130 
Quinolinic Acid 0.1 0.135 
Nicotinic Acid 0.1 0.:140 
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CHAPTER'IV 
• ~w• '. '. '", • :• ..._\ 
· l. . In·mammals the benzene ring of trypt0phan is oxidized via· 3-
hydroxyanthranilic acid,.0:-hydroxymuconic semialdehyde and-0:-hydroxymuconic 
-acid to glutaric acid .. The importance of this pathway-of tryptophan 
metabolism in organisms from several phyla has·been investigated by 
measuring the activities of three enzymes of this pathway: 3-hydroxy-
anthranilic acid oxidase, picolinic carboxylase and-a-hydroxymuconic 
semialdehyde dehydrogenase .. All of these three enzymes were found to 
occur in manunals, whereas no activity of these three enzymes was found 
in some organisms such as snail, earthworm, cockroach, grasshopper and 
- tetrahymena. High enzymatic activities of both}-hydroxyanthranilic acid 
oxidase and.picolinic-carboxylase were found in fish liver, but no a-
hydroxymuconic semialdehyde-dehydrogenase-was found .. The ability-of these 
various• organisms to· convert tryptophan-5-~14C and_ tryptophan-a:-l.~ · to 
· 
14C02 was· also examined. No l.4co2 was -recovered from either cockroach 
or grasshopper. Three to seven percent wasobtained from snail and 
earthworm .. These results·indicate that·the benzene ring of tryptophan 
is not oxidatively degraded in the insects studied and that it :is de-
graded in the snail and earthworm by a different pathway than in mammals • 
. 2. ·. Picolinic ca:tboxylase from beef .kidney has·been purified about 
-83-fold.· Some·properties of this-enzyme have also been studied. 
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Picolinic carboxylase is a stable enzyme, for which no cofactor could be 
demonstrated .. High concentrations• of annnonium sulfate· inhibit its· activity. 
· . The''Km ·value for the substrate,. Compound I, was determined to be 4. 1 x 
10~5». A broad pH optimum from 7. 5 to 8. 5 was observed. . Cu -H- ion. at a 
concentration of 1 x 10-4 M e<:>mpletely-inhibited enzymatic activity and 
·.·+r 
·· Ca . at the same concentration· produced 30% inhibition. Other divalent 
metal ions tested neither activate nor inactivate the enzyme .. Chelating 
agents such as 8-hydroxyquinoline,.a,a'-dipyridyl andEDTA do not produce 
a significant inhibition ofpicolinic catboxylase. However, pCMB., a 
sulfhydryl inhibitor) completely inhibits the enzymatic reaction at·. a 
concentration of 1 x 10-4 M. 
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